The surgical stapling device market is projected to be valued at USD 3,977.40 million in 2023. The market research report anticipates a growth of USD 5,930.60 million by 2033. The surgical stapling device sales are expected to record a CAGR of 4.10% during the forecast period.
Surgical Stapling Device Market Trends and Highlights
Attributes | Key Insights |
---|---|
Surgical Stapling Device Market Estimated Size in 2023 | USD 3,977.40 million |
Projected Market Value in 2033 | USD 5,930.60 million |
Value-based CAGR from 2023 to 2033 | 4.10% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The surgical stapling device market is projected to be valued at USD 3,977.40 million in 2023. The market research report anticipates a growth of USD 5,930.60 million by 2033.
A surgical stapling device improves dexterity and allows surgeons or gynecologists to improve their surgical skills and competence. The devices are increasingly being employed in various endoscopic procedures, colorectal surgery, and general surgery, among other procedures.
One of the stapling devices' distinguishing features is that it takes fewer hours to accomplish the process of wound closure. Surgical stapling devices are the surgeon's first choice in developed countries. This is expected to support the development of the surgical stapling devices market.
Sutured sites may have wound leakage and separation. Surgical staplers provide faster, more accurate, and more efficient wound closure, leading to increased adoption of stapling devices over traditional suturing methods.
Due to technological advancements, several market players are commercializing staplers used in surgical procedures. These devices can be used in various medical fields, which results in market growth in the projected period.
Market Value in 2022 | USD 3,827.50 million |
---|---|
Market Value in 2033 | USD 5,930.6 million |
The demand for surgical stapling devices has grown in tandem with the increasing adoption of minimally invasive surgeries.
Forecast CAGRs from 2023 to 2033
United States | 1.8% |
---|---|
Germany | 2.5% |
India | 6.2% |
China | 5.3% |
The United States is estimated to account for a CAGR of 1.8% in the surgical stapling devices market in 2023. In the United States, the growing geriatric population, the increasing number of surgical interventions, and the growing demand for improved medical technology all create significant potential possibilities for the surgical stapling devices market.
For instance, the recent National Centre for Health Statistics report shows approximately 50 million surgeries are performed annually in the United States. A high rate of obesity in the country and an increasing number of FDA approvals for non-invasive procedures are expected to support the development of the market.
The key players are focusing on inorganic growth strategies, such as partnerships and collaborations, and new product launches in the United States, which is anticipated to fuel the market demand.
Germany is expected to remain the most dominant country, estimated to account for a CAGR of 2.5% surgical stapling devices market in 2023. The growing awareness regarding the use of advanced surgical staplers over traditional sutures with favorable healthcare policies is expected to drive the market in Germany over the forecast period.
An increase in the prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases is projected to increase the number of surgeries performed, increasing the demand for stapling devices. An increase in investment in the market in Germany due to a sophisticated healthcare system is adding to the market growth.
The China surgical stapling devices market is expected to grow at a rapid rate. It will exhibit a CAGR of 5.3% in 2023 due to rising healthcare awareness and demand for advanced medical technology.
The rise in the number of surgeries performed, the growing geriatric population, and rising healthcare expenditure in China are expected to lead the market development in the coming years.
The Chinese healthcare system promotes the use of medical devices manufactured in China, and the medical devices of foreign make are partially reimbursed. This has promoted the manufacturing and use of medical devices that are made in China, leading to a considerably high number of medical device manufacturers in China. This, in turn, is leading to market development in China.
Demand for surgical stapling devices in India is expected to account for a CAGR of 6.2% in 2023. The increasing preferences for surgical stapling devices by surgeons and increasing healthcare expenditure are primary factors leading to market growth in India.
The key players in the market are also expanding their presence in this area. Increased government and private spending as a proportion of GDP (resulting in better healthcare facilities and infrastructure) adds to the market growth.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Segment | Manual Surgical Stapling Device (Product type) |
---|---|
Value Share (2023) | 87.7% |
By-product, the manual surgical stapling device segment is anticipated to hold the maximum share of 87.7% in 2023, expanding at a rapid rate during the forecast period owing to increasing demand for advanced technology.
The wide variety of benefits associated with manual staplers, such as manual stapling devices, are versatile and can be used in open surgeries as well as minimally invasive or laparoscopic procedures. They are widely used in various surgical specialties, including general surgery, gynecology, urology, and more.
Manual stapling devices provide a quicker and more consistent method of tissue closure compared to sutures are driving this segment's growth.
Segment | Disposable (Usage) |
---|---|
Value Share (2023) | 80.4% |
The disposable surgical stapling device segment will show the highest growth by usage and is expected to hold a revenue share of 80.4% in 2023.
The disposable segment is projected to show remarkable growth during the forecast years due to increased concerns regarding infectious diseases. Disposable staplers are standard as they decrease infections during surgical procedures, which ultimately enhances the technical quality.
The transmission of infections from patients to healthcare personnel can be avoided by discarding surgical staplers. The advantages of disposable staplers, such as the reduced risk of infection and superior product offerings, are expected to drive the demand for the segment.
Companies operating in the surgical stapling devices market are competitive by nature, with a few global and local competitors.
Key players in the global surgical stapling devices market are focusing on tapping emerging markets to increase market share and the consumer base through exclusive product launches and approval in the emerging market. Some of the recent instances include
Attributes | Details |
---|---|
Estimated Market Size in 2023 | USD 3,977.40 million |
Projected Market Valuation in 2033 | USD 5,930.60 million |
Value-based CAGR 2023 to 2033 | 4.10% |
Forecast Period | 2023 to 2033 |
Historical Data Available for | 2018 to 2022 |
Market Analysis | Value in USD million |
Key Regions Covered | North America; Latin America; Western Europe; Eastern Europe; South Asia and Pacific; East Asia; Middle East and Africa |
Key Market Segments Covered |
Product , Usage , Stapling type , Indication , End User , Region |
Key Countries Profiled |
The United States , Canada , Brazil , Mexico , Germany , The United Kingdom , France , Spain , Italy , Russia , Poland , Czech Republic , Romania , India , Bangladesh , Australia , New Zealand , China , Japan , South Korea , GCC countries , South Africa , Israel |
Key Companies Profiled | Medtronic plc.; Johnson & Johnson Services, Inc.; 3M Company; Dextera Surgical Inc.; Purple Surgical Holdings Limited; Meril Life Sciences Pvt. Ltd.; Grena Ltd. |
The surgical stapling devices market is expected to reach US$ 3,977.40 million in 2023.
The surgical stapling devices market is set to expand by a CAGR of 4.1% by 2033.
The surgical stapling devices market is forecast to reach US$ 5,930.60 million by 2033.
A significant share of profits will likely come from the Industry in North America.
The manual segment is expected to generate high revenue through 2033.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. Powered 5.2. Manual 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Usage 6.1. Disposable 6.2. Reusable 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Stapling Type 7.1. Straight 7.2. Curved 7.3. Circular 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication 8.1. Skin 8.2. Digestive Tract 8.3. Blood Vessels 8.4. Hernia 8.5. Lung 8.6. Others 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 9.1. Hospitals 9.2. Ambulatory Surgical Centers 9.3. Others 10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 10.1. North America 10.2. Latin America 10.3. Western Europe 10.4. Eastern Europe 10.5. South Asia and Pacific 10.6. East Asia 10.7. Middle East and Africa 11. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 17. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 18. Key Countries Market Analysis 19. Market Structure Analysis 20. Competition Analysis 20.1. Medtronic plc. 20.2. Johnson & Johnson Services, Inc. 20.3. 3M Company 20.4. Dextera Surgical Inc. 20.5. Purple Surgical Holdings Limited 20.6. Meril Life Sciences Pvt. Ltd. 20.7. Grena Ltd. 21. Assumptions & Acronyms Used 22. Research Methodology
Explore Healthcare Insights
View Reports